Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays.
Saved in:
| Title: | Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays. |
|---|---|
| Authors: | Partridge MA; Regeneron Pharmaceuticals, Tarrytown, New York, USA. michael.partridge@regeneron.com., Kamen L; BioAgilytix Labs, Durham, North Carolina, USA., Wu B; Johnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA., Solberg H; Novo Nordisk A/S, 2760, Måløv, Denmark., McNally J; Sword Bio, Chicago, IL, USA., Stevenson L; Immunologix Laboratories, Tampa, Florida, USA., Gupta S; Amgen, Thousand Oaks, California, USA., Liu S; Pfizer, Montreal, Quebec, Canada., Xu W; Merck & Co, Inc, Rahway, New Jersey, USA., Wu Y; BioData Solutions LLC, Lawrence, KS, USA., White J; BioData Solutions LLC, Lawrence, KS, USA. |
| Source: | The AAPS journal [AAPS J] 2025 Aug 13; Vol. 27 (5), pp. 132. Date of Electronic Publication: 2025 Aug 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1550-7416 |
|---|---|
| DOI: | 10.1208/s12248-025-01118-6 |
